肝动脉及部分脾动脉栓塞治疗肝癌伴脾功能亢进

目的：临床采用肝动脉栓塞化疗联合部分脾动脉栓治疗原发性肝癌合并脾功能亢进的效。方法：住院原了肝癌伴肝硬化脾功能亢进患者３４例，采用经皮穿刺肝动脉插管化疗栓塞及脾动脉部分栓塞治疗。治疗前后行检测肝功能、指标、外周血及Ｂ超、ＣＴ等。结果：术后ＣＴ随访显示肝脏瘤体缩小２４例，占７０．５８％（２４／３４），其中缩小５０％以上者１３例，２例治疗后肝功能行二期抹切除；脾脏栓塞后ＣＴ复查缩小，最多３４．７％，最

Hepatic Artery and Partial Splenic Artery Embolism in Treating Liver Cancer Concurred Hypersplenism

Purpose: To observe therapeutic effectiveness of combined embolism of hepatic artery and partial splenic artery in the treating primary liver cancer concurred hypersplenism. Method: We choosed 34 in-patients of primary liver cancer concurred cirrhosis and hypersplenism. They were given percutaneous puncture of liver artery heptic artery and partial splenic artery embolism combined with chemotherapy. We detected liver function, immune index, blood routine, B-US and CT. Result: CT result following up operation showed 24 cases' liver tumor shrinked, occupied 70.58% (24/34). Of them 13 cases shrinked more than 50% . 2 cases had secondary operation after treatment. After embolism, spleen shrinked by checking CT. The most one was 34.7% and the least one was 20.0 % . AFP declined with different effect. 23 cases liver function developed. Immune index had no change before and after treatment. WBC, RBC, and PT all developed by dynamic observation of blood routine. Especially PT elevated significantly after treatment (P <0.01). Conclusion: Embolizing liver artery and partial splenic artery combined with chemotherapy can shrink liver, tumor, remit, remit hypersplenism. So it was an effective method to treat medium and late stage liver cancer.